StockData

Essent vs Octave Specialty

ESNT and OSG side by side, both in insurance carriers. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ESNT and OSG compare

Essent is the larger company, worth 24 times as much as Octave Specialty ($5.9B against $240M).

Octave Specialty grew revenue faster over the last twelve months (26.8% versus 4.3% for Essent).

Essent keeps more of each dollar of sales as profit, with a net margin of 51.5% compared with −49.6% at Octave Specialty.

Essent pays a dividend yielding 1.6%; Octave Specialty does not pay one.

Essent scores higher on the StockData Score (10 against 4 for Octave Specialty), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricESNTOSG
Size and price
Market cap$5.9B$240M
Share price$65.23$5.32
Change, 1 year6.6%−44.1%
Change, 5 years52.2%−64.7%
Beta (5Y)0.360.51
Employees514275
StockData Score
Total score10 (better)4
Valuation score3 (better)2
Growth score02 (better)
Performance score3 (better)0
Health score00
Dividend score4 (better)0
Valuation
P/E9.1×–
P/S4.4×0.7× (better)
P/B1.0×0.3× (better)
EV/EBITDA6.7×–
P/FCF7.1×–
FCF yield14.1%–
Fair value$76.42–
Margin of safety14.6%–
Growth
Revenue growth (TTM)4.3%26.8% (better)
Revenue growth, 5Y average5.7%10.0% (better)
Net income growth (TTM)−4.8%–
EPS growth (TTM)4.7%–
EPS growth, 5Y average12.2%–
Profitability
Net margin51.5% (better)−49.6%
FCF margin62.4%–
Return on equity12.0% (better)−20.4%
Financial health
Altman Z-score3.02 (better)0.47
Piotroski F-score5 (better)4
Dividends and buybacks
Dividend yield1.6%–
Payout ratio18.2%–
Years of dividend growth6–
Dividend growth, 5Y average14.1%–
Buyback yield10.4%–
Shareholder yield12.0% (better)0.00%
Ownership
Held by institutions96.7%66.7%
Held by insiders3.7%6.2%
Insider net buying, 12 months−$19.9M$91.1K (better)
Short interest, % of float4.0%3.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.